As IL-6 plays a major role in COVID-19 pathophysiology29, and IL-6 blockers have a treatment effect34, the additional treatment effect of higher doses of corticosteroids is likely to be smaller in patients receiving IL-6 inhibitors. Here, IL6 is linked to COVID-19.